Evidence map›Paper›PMID 20840077›Full record

ReviewCurrent drug targets2010

Targeting karyotypic complexity and chromosomal instability of cancer cells.

Anna V Roschke, Ilan R Kirsch

Open access · bronzeAbstract readReview
In one paragraph

Review in Current drug targets, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Bioenergetics of life, disease and death phenomena.Theory in biosciences = Theorie in den Biowissenschaften · 2018
    Article
  11. Article
  12. Article
  13. Centrosome amplification, chromosomal instability and cancer: mechanistic, clinical and therapeutic issues.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2016
    Review
  14. Genomic Instability and Cancer.Journal of carcinogenesis & mutagenesis · 2014
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Anna V RoschkeGenetics Branch, Center for Cancer Research, National Cancer Institute, Building NNMC8, Room 5101, Bethesda, MD 20889-5105, USA. roschkea@mail.nih.gov
Ilan R Kirsch
National Cancer Institute · US

Funding

Molecular Cytogenetics CoreZICBC010930 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ROSCHKE, ANNA · 2009 to 2014
$2.4M
Molecular Cytogenetics CoreZ01BC010930 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ROSCHKE, ANNA · 2008 to 2008
$374k
Intramural NIH HHS Z01 BC010930Intramural NIH HHS Z99 CA999999NCI NIH HHS Y99 CA999999
6 · The paper itself

Abstract

Multiple karyotypic abnormalities and chromosomal instability are characteristic features of many cancers that are relatively resistant to chemotherapeutic agents currently used in the clinic. These same features represent potentially targetable "states" that are essentially tumor specific. The assessment of the chromosomal state of a cancer cell population may provide a guide for the selection or development of drugs active against aggressive and intractable cancers.

Indexed as

Chromosomal InstabilityAnimalsAntineoplastic AgentsChromosome AberrationsDrug Delivery SystemsDrug DesignDrug Resistance, NeoplasmHumansNeoplasmsPhenotypeAntineoplastic Agents

Identifiers

PMID20840077
PMCPMC3309604
OpenAlexW2016129219

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.